Advertisement
top banner image  

topleft corner image     top right corner image
 
ACCF/AHA Clinical Guidelines and Statements

CME logo image
bullet
bullet
bullet
bullet

JACC Homepage JACC Imaging Homepage
Still not a subscriber to JACC Imaging or JACC Interventions?

take action
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

acc links
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

jacc interventions image
bullet
bullet
bullet
bullet

     top nav image

     

J Am Coll Cardiol Intv, 2008; 1:14-21, doi:10.1016/j.jcin.2007.10.004
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aoki, J.
Right arrow Articles by Dangas, G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Aoki, J.
Right arrow Articles by Dangas, G.

Review Article

Coronary Artery Aneurysms After Drug-Eluting Stent Implantation

Jiro Aoki, MD, PhD, Ajay Kirtane, MD, SM, Martin B. Leon, MD, FACC, George Dangas, MD, PhD, FACC*

Columbia University Medical Center, the Cardiovascular Research Foundation, New York, New York.

* Reprint requests and correspondence: Dr. George Dangas, Associate Professor of Clinical Medicine, Columbia University Medical Center, 111 East 59th Street, 11th Floor, New York, New York 10022. (Email: gdangas{at}crf.org).

Drug-eluting stents (DES), which locally elute antiproliferative drugs, can dramatically inhibit neointimal growth. However, several pathological studies have indicated that DES may delay healing after vascular injury, and DES implantation may be theoretically associated with a risk of coronary artery aneurysm formation. Coronary aneurysms have been reported from 3 days to up to 4 years after DES implantation procedures, with varying clinical presentations. The incidence of coronary artery aneurysms after DES implantation is low within the first 9 months, with a reported incidence of 0.2% to 2.3%, a rate similar to that reported after bare-metal stent (BMS) implantation (0.3% to 3.9%) in the DES versus BMS randomized trials. However, the true incidence of coronary aneurysms in an unselected patient population is still largely unknown. This article reviews the published literature on coronary artery aneurysms specifically relating to DES.

Abbreviations and Acronyms
  BMS = bare-metal stent(s)
  CTA = computed tomography angiography
  DES = drug-eluting stent(s)
  IVUS = intravascular ultrasound




This article has been cited by other articles:


Home page
Interact CardioVasc Thorac SurgHome page
A. D. Furtado, S. P. S. Bhat, S. M. Peer, and R. Chikkatur
Infected pseudoaneurysm involving a drug-eluting stent
Interact CardioVasc Thorac Surg, April 1, 2011; 12(4): 636 - 638.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Garg and P. W. Serruys
Coronary Stents: Current Status
J. Am. Coll. Cardiol., August 31, 2010; 56(10_Suppl_S): S1 - S42.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
F. Alfonso, M.-J. Perez-Vizcayno, M. Ruiz, A. Suarez, M. Cazares, R. Hernandez, J. Escaned, C. Banuelos, P. Jimenez-Quevedo, and C. Macaya
Coronary Aneurysms After Drug-Eluting Stent Implantation: Clinical, Angiographic, and Intravascular Ultrasound Findings
J. Am. Coll. Cardiol., June 2, 2009; 53(22): 2053 - 2060.
[Abstract] [Full Text] [PDF]



Advertisement
 
   
 
home link current link search link archive link topics link cardiology careers link